Trials / Conditions / Triple-Negative Breast Neoplasm
Triple-Negative Breast Neoplasm
3 registered clinical trials studyying Triple-Negative Breast Neoplasm — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC NCT07011823 | Gangnam Severance Hospital | Phase 2 |
| Active Not Recruiting | Tracking Triple-negative Breast Cancer Evolution Through Therapy NCT03077776 | UNICANCER | N/A |
| Withdrawn | A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Canc NCT02685306 | Peregrine Pharmaceuticals | Phase 2 |